Oncología Traslacional
ONCTRAS
![Foto de Oncología Traslacional](/img/uploaded/8edbe5178cdb32cce4e7d9c57e11add8.jpg)
![Foto de Hospital Universitario 12 de Octubre](/img/noimage_org.png)
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (37)
2024
-
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/ MINOVA Study)
Clinical Cancer Research, Vol. 30, Núm. 1, pp. 176-186
-
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Journal of Clinical Oncology, Vol. 42, Núm. 1, pp. 47-58
2023
-
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
Frontiers in Immunology, Vol. 14
-
Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer
Annals of Surgical Oncology, Vol. 30, Núm. 12, pp. 7653-7662
-
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: A stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601
International Journal of Gynecological Cancer, Vol. 33, Núm. 6, pp. 929-936
-
Novel therapies leading to a new landscape in gynecologic tumors
International Journal of Gynecological Cancer
-
Oncological outcomes among young women with non-epithelial ovarian cancer: The YOC-Care study (Young Ovarian Cancer - Care)
International Journal of Gynecological Cancer, Vol. 33, Núm. 6, pp. 915-921
-
Outcomes and endpoints of relevance in gynecologic cancer clinical trials
International Journal of Gynecological Cancer, Vol. 33, Núm. 3, pp. 323-332
-
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme
European Journal of Cancer, Vol. 182, pp. 3-14
2022
-
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
ESMO Open, Vol. 7, Núm. 5
-
OVA-LEAK: Prognostic score for colo-rectal anastomotic leakage in patients undergoing ovarian cancer surgery
Gynecologic Oncology, Vol. 167, Núm. 1, pp. 22-27
-
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study
BMC Cancer, Vol. 22, Núm. 1
2021
-
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
Annals of Oncology, Vol. 32, Núm. 10, pp. 1245-1255
-
Management of advanced ovarian cancer in Spain: an expert Delphi consensus
Journal of Ovarian Research, Vol. 14, Núm. 1
-
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
ESMO open, Vol. 6, Núm. 4, pp. 100212
-
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic
British Journal of Surgery, Vol. 108, Núm. 1, pp. 88-96
-
SEOM clinical guideline in ovarian cancer (2020)
Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 961-968
2020
-
Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction
Gynecologic Oncology, Vol. 158, Núm. 3, pp. 603-607
-
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
The Lancet Oncology, Vol. 21, Núm. 4, pp. 519-530
2019
-
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer
International Journal of Gynecological Cancer, Vol. 29, Núm. 6, pp. 1050-1056